What is the appropriate starting dose and titration schedule for propranolol in an adult without contraindications?

Starting Propranolol in Adults

For hypertension in adults without contraindications, start propranolol immediate-release at 80 mg daily divided into two doses (40 mg twice daily), then titrate upward every 3-7 days based on blood pressure response to a usual maintenance dose of 160-320 mg daily in divided doses. 1, 2, 3

Indication-Specific Dosing

The starting dose and titration schedule varies significantly by indication:

Hypertension

• Starting dose: 80 mg/day in divided doses (immediate-release) or 80 mg once daily (extended-release)
• Titration: Increase gradually every 3-7 days
• Usual maintenance: 120-160 mg once daily (extended-release) or 160-320 mg/day in divided doses (immediate-release)
• Maximum: Up to 640 mg/day may be required in some cases 1, 2, 3

The 2017 ACC/AHA hypertension guidelines specify propranolol IR at 80-160 mg/day in 2 divided doses, or propranolol LA at 80-160 mg once daily 1, 2. Beta blockers are not recommended as first-line agents for hypertension unless the patient has ischemic heart disease or heart failure 1, 2.

Angina Pectoris

• Starting dose: 80 mg once daily (extended-release)
• Titration: Increase at 3-7 day intervals
• Usual effective dose: 160 mg once daily
• Maximum: 320 mg/day (safety beyond this not established) 3

Acute Tachyarrhythmias (IV)

For acute management of narrow-complex tachycardias or rate control in atrial fibrillation:

• IV dose: 0.5-1 mg over 1 minute, repeated up to total dose of 0.1 mg/kg if required
• Oral conversion: 40-80 mg every 6-8 hours, starting 1-2 hours after IV dose 4

Migraine Prophylaxis

• Starting dose: 80 mg once daily (extended-release)
• Usual effective range: 160-240 mg once daily
• Trial duration: If no response after 4-6 weeks at maximum dose, discontinue 3

Formulation Considerations

Immediate-release vs. extended-release formulations are NOT interchangeable on a mg-for-mg basis. Extended-release formulations have different kinetics and produce lower blood levels, requiring retitration 3. Research shows that immediate-release propranolol given twice daily provides equivalent beta-blockade to three-times-daily dosing, making twice-daily dosing preferable 5.

Critical Safety Monitoring

Absolute Contraindications

• Asthma or severe reactive airway disease
• Decompensated heart failure
• Second or third-degree heart block
• Severe bradycardia (HR <50 bpm)
• Hypotension (SBP <90 mmHg)
• Cardiogenic shock 4, 6

Initial Monitoring Requirements

When starting propranolol, monitor:

• Heart rate: Target resting HR 50-60 bpm
• Blood pressure: Check for hypotension
• ECG monitoring during IV administration
• Auscultation for rales (heart failure) and bronchospasm 6

Common Pitfalls to Avoid

1. Never abruptly discontinue propranolol - this can precipitate rebound hypertension, angina, or myocardial infarction. Taper gradually over several weeks 1, 2, 7, 3

2. Avoid in acute decompensated states - Patients with evidence of low cardiac output (oliguria, sinus tachycardia reflecting low stroke volume) should not receive beta-blockers until stabilized 6

3. Use caution with chronic obstructive pulmonary disease - If beta-blocker needed, start with low doses of a beta-1-selective agent (metoprolol preferred over propranolol, which is non-selective) 6

4. Dose timing matters for extended-release - Some chronotherapeutic formulations are designed for evening dosing to provide maximum effect during morning hours when cardiovascular events peak 8

5. Monitor for drug interactions - Propranolol is a CYP2D6 substrate and can interact with numerous medications 1, 2

Special Populations

Pregnancy: Propranolol should be avoided in pregnancy when possible, as it has been associated with growth restriction and lower fetal weight. Labetalol is the preferred beta-blocker with the most reassuring fetal safety data 9.

Elderly: Start at lower doses and titrate more cautiously due to increased risk of hypotension and bradycardia.

Practical Titration Algorithm

1. Baseline assessment: Check HR, BP, ECG if indicated; rule out contraindications
2. Start low: 40 mg twice daily (IR) or 80 mg once daily (ER) for hypertension
3. Monitor response: Check BP and HR after 3-7 days
4. Titrate upward: Increase by 40-80 mg/day increments until target BP achieved or limiting side effects occur
5. Maintenance: Most patients require 160-320 mg/day in divided doses
6. Reassess: Full antihypertensive response may take days to weeks 3, 10